Immunological aspects of 22q11.2 deletion syndrome

Cellular and Molecular Life Sciences

Volumn 69, Issue 1, 2012, Pages 17-27

  Gennery, A R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

22q11 deletion; Autoimmunity; CHARGE syndrome; DiGeorge syndrome; Velo cardio facial syndrome

Indexed keywords

ANTIBIOTIC AGENT;

ADOPTIVE TRANSFER; AUTOIMMUNITY; CELL MATURATION; CHROMOSOME DELETION 22Q11; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; CONGENITAL HEART MALFORMATION; DIGEORGE SYNDROME; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; LUNG INFECTION; LYMPHOCYTE DEPLETION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SYNDROME CHARGE; T LYMPHOCYTE; THYMUS TRANSPLANTATION; VELOCARDIOFACIAL SYNDROME;

ABNORMALITIES, MULTIPLE; AUTOIMMUNE DISEASES; CENTRAL TOLERANCE; CHARGE SYNDROME; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; T-LYMPHOCYTES; THYMUS GLAND;

EID: 84856225980     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0842-z     Document Type: Review

References (100)

1. LJ Kobrynski KE Sullivan 2007 Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes Lancet 370 1443 1452 17950858 10.1016/S0140-6736(07)61601-8 1:CAS:528:DC%2BD2sXhtF2hu7rM (Pubitemid 47576169)
2. E Perez KE Sullivan 2002 Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes) Curr Opin Pediatr 14 678 683 12436034 10.1097/00008480-200212000-00005 (Pubitemid 35333127)
3. RJ Shprintzen AM Higgins K Antshel W Fremont N Roizen W Kates 2005 Velo-cardio-facial syndrome Curr Opin Pediatr 17 725 730 16282778 10.1097/01.mop.0000184465.73833.0b (Pubitemid 41689665)
4. H Yamagashi D Srivastava 2003 Unravelling the genetic and developmental mysteries of 22q11 deletion syndrome Trends Mol Med 9 383 389 10.1016/S1471-4914(03)00141-2 (Pubitemid 37169052)
5. LA Jerome VE Papaioannou 2001 DiGeorge syndrome phenotype in mice mutant for the T box gene, Tbx1 Nat Genet 27 286 291 11242110 10.1038/85845 1:CAS:528:DC%2BD3MXhslOjur8%3D (Pubitemid 32201849)
6. MD Cooper RDA Peterson RA Good 1965 A new concept of the cellular basis of immunity J Pediatr 67 907 908 10.1016/S0022-3476(65)81796-6
7. A de la Chapelle R Herva M Koivisto P Aula 1981 A deletion in chromosome 22 can cause DiGeorge syndrome Hum Genet 57 253 256 (Pubitemid 11121071)
8. RI Kelley EH Zackai BS Emanuel M Kistenmacher F Greenberg HH Punnett 1982 The association of the DiGeorge anomalad with partial monosomy of chromosome 22 J Pediatr 101 197 200 7097410 10.1016/S0022-3476(82)80116-9 1:STN:280:DyaL383ktFCjtQ%3D%3D (Pubitemid 12098766)
9. DA Driscoll NB Spinner ML Budarf DM McDonald-McGinn EH Zackai RB Goldberg RJ Shprintzen HM Saal J Zonana MC Jones 1992 Deletions and microdeletions of 22q11.2 in velo-cardio-fa-cial syndrome Am J Med Genet 44 261 268 1360769 10.1002/ajmg.1320440237 1:STN:280:DyaK3s%2FovFelsQ%3D%3D
10. R Matsuoka A Takao M Kimura S Imamura C Kondo K Joh-o K Ikeda M Nishibatake M Ando K Momma 1994 Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2 Am J Med Genet 53 285 289 7856665 10.1002/ajmg.1320530314 1:STN:280:DyaK2M7mtVSnsg%3D%3D (Pubitemid 24362425)
11. DM McDonald-McGinn DA Driscoll L Bason K Christensen D Lynch K Sullivan D Canning W Zavod N Quinn J Rome 1995 Autosomal dominant "Opitz" GBBB syndrome due to a 22q11.2 deletion Am J Med Genet 59 103 113 8849001 10.1002/ajmg.1320590122 1:STN:280:DyaK287ht1Cgsg%3D%3D
12. K Devriendt A Swillen JP Fryns 1998 Deletion in chromosome region 22q11 in a child with CHARGE association Clin Genet 53 408 410 9660062 10.1111/j.1399-0004.1998.tb02755.x 1:STN:280:DyaK1czitFCquw%3D%3D (Pubitemid 28252107)
13. H Yagi Y Furutani H Hamada T Sasaki S Asakawa S Minoshima F Ichida K Joo M Kimura S Imamura N Kamatani K Momma A Takao M Nakazawa N Shimizu R Matsuoka 2003 Role of TBX1 in human del22q11.2 syndrome Lancet 362 1366 1373 14585638 10.1016/S0140-6736(03)14632-6 1:CAS:528:DC%2BD3sXosVKkurs%3D (Pubitemid 37338337)
14. F Greenberg C Valdes HM Rosenblatt JL Kirkland DH Ledbetter 1986 Hypoparathyroidism and T cell immune defect in a patient with 10p deletion syndrome J Pediatr 109 489 492 3509963 10.1016/S0022-3476(86)80124-X 1:STN:280:DyaL28zgsleiuw%3D%3D (Pubitemid 16014278)
15. G Monaco F Ciccimarra C Pignata S Garofalo 1989 T cell immunodeficiency in a patient with 10p deletion syndrome J Pediatr 115 330 2754563 1:STN:280:DyaL1MzivVOjuw%3D%3D
16. G Monaco C Pignata E Rossi O Mascellaro S Cocozza F Ciccimarra 1991 DiGeorge anomaly associated with 10p deletion Am J Med Genet 39 215 216 2063928 10.1002/ajmg.1320390220 1:STN:280:DyaK3M3ptVWhtQ%3D%3D
17. KE Sullivan AF Jawad P Randall DA Driscoll BS Emanuel DM McDonald-McGinn EH Zackai 1998 Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes Clin Immunol Immunopathol 86 141 146 9473376 10.1006/clin.1997.4463 1:STN:280:DyaK1c7ktF2qtA%3D%3D (Pubitemid 28081550)
18. D Johnson N Morrison L Grant T Turner J Fantes JM Connor V Murday 2006 Confirmation of CHD7 as a cause of CHARGE association identified by mapping a balanced chromosome translocation in affected monozygotic twins J Med Genet 43 280 284 16118347 10.1136/jmg.2005.032946 1:CAS:528:DC%2BD28XjsFams78%3D
19. AR Gennery MA Slatter J Rice LH Hoefsloot D Barge A McLean-Tooke T Montgomery JA Goodship AD Burt TJ Flood M Abinun AJ Cant D Johnson 2008 Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell+ severe combined immune deficiency and may cause Omenn-like syndrome Clin Exp Immunol 153 75 80 18505430 10.1111/j.1365-2249.2008.03681.x 1:STN:280:DC%2BD1cvgs1ajtg%3D%3D (Pubitemid 351809347)
20. C Carlson H Sirotkin R Pandita R Goldberg J McKie R Wadey SR Patanjali SM Weissman K Anyane-Yeboa D Warburton P Scrambler R Shprintzen R Kucherlapati BE Morrow 1997 Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients Am J Hum Genet 61 620 629 9326327 10.1086/515508 1:CAS:528:DyaK2sXmsV2ks7w%3D (Pubitemid 27418403)
21. L Edelmann RK Pandita BE Morrow 1999 Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome Am J Hum Genet 64 1076 1086 10090893 10.1086/302343 1:STN:280:DyaK1M7pt1emtg%3D%3D (Pubitemid 30463039)
22. DW Meechan TM Maynard D Gopalakrishna Y Wu AS LaMantia 2007 When half is not enough: gene expression and dosage in the 22q11 deletion syndrome Gene Expr 13 299 310 17708416 10.3727/000000006781510697 1:STN:280:DC%2BD2svovFyjsQ%3D%3D (Pubitemid 47289403)
23. I Taddei M Morishima T Huynh EA Lindsay 2001 Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes Proc Natl Acad Sci USA 98 11428 11431 11562466 10.1073/pnas.201127298 1:CAS:528:DC%2BD3MXnt1yqurg%3D (Pubitemid 32928745)
24. M Schinke S Izumo 2001 Deconstructing DiGeorge syndrome Nat Genet 27 238 240 11242098 10.1038/85784 1:CAS:528:DC%2BD3MXhslCrtLs%3D (Pubitemid 32201840)
25. LA Jerome VE Papaioannou 2001 DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1 Nat Genet 27 286 291 11242110 10.1038/85845 1:CAS:528:DC%2BD3MXhslOjur8%3D (Pubitemid 32201849)
26. DL Guris J Fantes D Tara BJ Druker A Imamoto 2001 Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome Nat Genet 27 293 298 11242111 10.1038/85855 1:CAS:528:DC%2BD3MXhslOjurs%3D (Pubitemid 32201850)
27. DL Guris G Duester VE Papaioannou A Imamoto 2006 Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome Dev Cell 10 81 92 16399080 10.1016/j.devcel.2005.12.002 1:CAS:528:DC%2BD28Xht1Sqt7Y%3D (Pubitemid 43025679)
28. KL van Bueren I Papangeli F Rochais K Pearce C Roberts A Calmont D Szumska RG Kelly S Bhattacharya PJ Scambler 2010 Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome Dev Biol 340 369 380 20122914 10.1016/j.ydbio.2010.01. 020
29. CG Marfella AN Imbalzano 2007 The Chd family of chromatin remodelers Mutat Res 618 30 40 17350655 10.1016/j.mrfmmm.2006.07.012 1:CAS:528: DC%2BD2sXksFahuro%3D (Pubitemid 46574742)
30. JE Sillibourne B Delaval S Redick M Sinah SJ Doxsey 2007 Chromatin remodeling proteins interact with pericentrin to regulate centrosome integrity Mol Biol Cell 18 3667 3680 17626165 10.1091/mbc.E06-07-0604 1:CAS:528: DC%2BD2sXhtVWntL7M (Pubitemid 47378703)
31. M Aramaki T Kimura T Udaka R Kosaki T Mitsuhashi Y Okada T Takahashi K Kosaki 2007 Embryonic expression profile of chicken CHD7, the ortholog of the causative gene for CHARGE syndrome Birth Defects Res A Clin Mol Teratol 79 50 57 17149726 10.1002/bdra.20330 1:CAS:528:DC%2BD2sXmsleiuw%3D%3D (Pubitemid 46053411)
32. D Sanlaville HC Etchevers M Gonzales J Martinovic M Clément-Ziza AL Delezoide MC Aubry A Pelet S Chemouny C Cruaud S Audollent C Esculpavit G Goudefroye C Ozilou C Fredouille N Joye N Morichon-Delvallez Y Dumez J Weissenbach A Munnich J Amiel F Encha-Razavi S Lyonnet M Vekemans T Attié-Bitach 2006 Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development J Med Genet 43 211 217 16169932 10.1136/jmg.2005.036160 1:CAS:528: DC%2BD28XjsFanurY%3D
33. P de Lonlay-Debeney V Cormier-Daire J Amiel V Abadie S Odent A Paupe S Couderc AL Tellier D Bonnet M Prieur M Vekemans A Munnich S Lyonnet 1997 Features of DiGeorge syndrome and CHARGE association in five patients J Med Genet 34 986 989 9429139 10.1136/jmg.34.12.986 (Pubitemid 27522102)
34. ML Markert BH Devlin MJ Alexieff J Li EA McCarthy SE Gupton IK Chinn LP Hale TB Kepler M He M Sarzotti MA Skinner HE Rice JC Hoehner 2007 Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants Blood 109 4539 4547 17284531 10.1182/blood-2006-10-048652 1:CAS:528:DC%2BD2sXls1amtr8%3D (Pubitemid 46743425)
35. G Holländer J Gill S Zuklys N Iwanami C Liu Y Takahama 2006 Cellular and molecular events during early thymus development Immunol Rev 209 28 46 16448532 10.1111/j.0105-2896.2006.00357.x
36. CS Le Lievre NM Le Douarin 1975 Mesenchymal derivatives of the neural crest: analysis of chimeric quail and chick embryos J Embryol Exp Morphol 34 125 154 1185098 1:STN:280:DyaE28%2FkslartQ%3D%3D
37. BF Haynes CS Heinly 1995 Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment J Exp Med 181 1445 1458 7699329 10.1084/jem.181.4.1445 1:CAS:528:DyaK2MXkslWnt7k%3D
38. PL Poliani F Facchetti M Ravanini AR Gennery A Villa CM Roifman LD Notarangelo 2009 Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome Blood 114 105 108 19414857 10.1182/blood-2009-03-211029 1:CAS:528:DC%2BD1MXhtVOkurrE
39. J Gill M Malin J Sutherland D Gray G Hollander R Boyd 2003 Thymic generation and regeneration Immunol Rev 195 28 50 12969308 10.1034/j.1600-065X. 2003.00077.x 1:CAS:528:DC%2BD3sXotFyrt7o%3D (Pubitemid 37153451)
40. T Akiyama Y Shimo H Yanai J Qin D Ohshima Y Maruyama Y Asaumi J Kitazawa H Takayanagi JM Penninger M Matsumoto T Nitta Y Takahama J Inoue 2008 The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance Immunity 29 423 437 18799149 10.1016/j.immuni.2008.06.015 1:CAS:528:DC%2BD1cXhtF2jtLjK
41. S Zuklys G Balciunaite A Agarwal E Fasler-Kan E Palmer GA Holländer 2000 Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis- ectodermal dystrophy (APECED) J Immunol 165 1976 1983 10925280 1:CAS:528:DC%2BD3cXls1KmsL8%3D (Pubitemid 30648747)
42. N Watanabe YH Wang HK Lee T Ito YH Wang W Cao YJ Liu 2005 Hassall's corpuscles instruct dendritic cells to induce CD4+ CD25+ regulatory T cells in human thymus Nature 436 1181 1185 16121185 10.1038/nature03886 1:CAS:528:DC%2BD2MXovVOgtrw%3D (Pubitemid 41232298)
43. SM Müller T Kohn AS Schulz KM Debatin W Friedrich 2000 Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation Blood 96 4344 4349 11110711
44. Finnish-German APECED Consortium 1997 An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains Nat Genet 17 399 403 10.1038/ng1297-399
45. CL Bennett J Christie F Ramsdell ME Brunkow PJ Ferguson L Whitesell TE Kelly FT Saulsbury PF Chance HD Ochs 2001 The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 20 21 11137993 10.1038/83713 1:CAS:528: DC%2BD3MXis1yluw%3D%3D (Pubitemid 32044513)
46. PL Poliani W Vermi F Facchetti 2009 Thymus microenvironment in human primary immunodeficiency diseases Curr Opin Allergy Clin Immunol 9 489 495 19841578 10.1097/ACI.0b013e3283327e5c
47. K Writzl CM Cale CM Pierce LC Wilson RC Hennekam 2007 Immunological abnormalities in CHARGE syndrome Eur J Med Genet 50 338 345 17684005 10.1016/j.ejmg.2007.05.002 (Pubitemid 47432914)
48. AK Ryan JA Goodship DI Wilson N Philip A Levy H Seidel S Schuffenhauer H Oechsler B Belohradsky M Prieur A Aurias FL Raymond J Clayton-Smith E Hatchwell C McKeown FA Beemer B Dallapiccola G Novelli JA Hurst J Ignatius AJ Green RM Winter L Brueton K Brøndum-Nielsen PJ Scambler 1997 Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study J Med Genet 34 798 804 9350810 10.1136/jmg.34.10.798 1:STN:280:DyaK1c%2FhtVaqsQ%3D%3D (Pubitemid 27417432)
49. JCK Barber JM Walker MR Barker AW McNinch RJ Hallett 1996 Repeated cytogenetic culture failure as an indicator of immunodeficiency Lancet 348 1518 8942803 10.1016/S0140-6736(05)65936-3 1:STN:280:DyaK2s%2FpvValsA%3D%3D (Pubitemid 26400263)
50. JG Ocejo-Vinyals MJ Lozano P Sánchez-Velasco J Escribano de Diego JE Paz-Miguel F Leyva-Cobián 2000 An unusual concurrence of graft versus host disease caused by engraftment of maternal lymphocytes with DiGeorge anomaly Arch Dis Child 83 165 169 10906029 10.1136/adc.83.2.165 1:STN:280: DC%2BD3cvgtVaktw%3D%3D (Pubitemid 30670431)
51. SM Müller M Ege A Pottharst AS Schulz K Schwarz W Friedrich 2001 Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients Blood 98 1847 1851 11535520 10.1182/blood.V98.6.1847
52. ML Markert MJ Alexieff J Li M Sarzotti DA Ozaki BH Devlin GD Sempowski ME Rhein P Szabolcs LP Hale RH Buckley KE Coyne HE Rice SM Mahaffey MA Skinner 2004 Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases J Allergy Clin Immunol 113 734 741 15100681 10.1016/j.jaci.2004.01.766 1:CAS:528:DC%2BD2cXjt1alt74%3D (Pubitemid 38530431)
53. A Janda P Sedlacek M Hönig W Friedrich M Champagne T Matsumoto A Fischer B Neven A Contet D Bensoussan P Bordigoni D Loeb W Savage N Jabado FA Bonilla MA Slatter EG Davies AR Gennery 2010 Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly Blood 116 2229 2236 20530285 10.1182/blood-2010-03-275966 1:CAS:528:DC%2BC3cXhtlWrtLrJ
54. SA McGhee MG Lloret ER Stiehm 2009 Immunologic reconstitution in 22q deletion (DiGeorge) syndrome Immunol Res 45 37 45 19238335 10.1007/s12026-009- 8108-7
55. Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, Amrolia PJ, Gaspar HB, Davies EG, Friedrich W, Hoenig M, Notarangelo LD, Mazzolari E, Porta F, Bredius RG, Lankester AC, Wulffraat NM, Seger R, Güngör T, Fasth A, Sedlacek P, Neven B, Blanche S, Fischer A, Cavazzana-Calvo M, Landais P, Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation, European Society for Immunodeficiency (2010) Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 126, 602-10.e1-11
56. B Neven S Leroy H Decaluwe F Le Deist C Picard D Moshous N Mahlaoui M Debré JL Casanova L Dal Cortivo Y Madec S Hacein-Bey-Abina G de Saint Basile JP de Villartay S Blanche M Cavazzana-Calvo A Fischer 2009 Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency Blood 113 4114 4124 19168787 10.1182/blood-2008-09-177923 1:CAS:528:DC%2BD1MXlsVWrtrY%3D
57. Cleveland WW, Fogel BJ, Brown WT, Kay HE (1968) Foetal thymic transplant in a case of DiGeorge's syndrome. Lancet (7580), 1211-1214
58. August CS, Berkel AI, Levey RH, Rosen FS, Kay HE (1970). Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet (7656):1080-1083
59. ML Markert A Boeck LP Hale AL Kloster TM McLaughlin MN Batchvarova DC Douek RA Koup DD Kostyu FE Ward HE Rice SM Mahaffey SE Schiff RH Buckley BF Haynes 1999 Transplantation of thymus tissue in complete DiGeorge syndrome N Engl J Med 341 1180 1189 10523153 10.1056/NEJM199910143411603 1:STN:280:DyaK1MvjsFGnsA%3D%3D (Pubitemid 29480656)
60. ML Markert BH Devlin EA McCarthy 2010 Thymus transplantation Clin Immunol 135 236 246 20236866 10.1016/j.clim.2010.02.007 1:CAS:528:DC%2BC3cXkvFenu74%3D
61. ML Markert M Sarzotti DA Ozaki GD Sempowski ME Rhein LP Hale F Le Deist MJ Alexieff J Li ER Hauser BF Haynes HE Rice MA Skinner SM Mahaffey J Jaggers LD Stein MR Mill 2003 Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients Blood 102 1121 1130 12702512 10.1182/blood-2002-08-2545 1:CAS:528:DC%2BD3sXlvFCmtLY%3D (Pubitemid 36917815)
62. ML Markert MJ Alexieff J Li M Sarzotti DA Ozaki BH Devlin DA Sedlak GD Sempowski LP Hale HE Rice SM Mahaffey MA Skinner 2004 Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome Blood 104 2574 2581 15100156 10.1182/blood-2003-08-2984 1:CAS:528:DC%2BD2cXovVegur8%3D (Pubitemid 39331863)
63. IK Chinn BH Devlin YJ Li ML Markert 2008 Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly Clin Immunol 126 277 281 18155964 10.1016/j.clim.2007.11.009 1:CAS:528:DC%2BD1cXitVWlu7k%3D
64. ML Markert BH Devlin IK Chinn EA McCarthy YJ Li 2008 Factors affecting success of thymus transplantation for complete DiGeorge anomaly Am J Transplant 8 1729 1736 18557726 10.1111/j.1600-6143.2008.02301.x 1:STN:280: DC%2BD1crhtVGlsw%3D%3D
65. A Liston S Lesage J Wilson L Peltonen CC Goodnow 2003 Aire regulates negative selection of organ-specific T cells Nat Immunol 4 350 354 12612579 10.1038/ni906 1:CAS:528:DC%2BD3sXitlyqs7w%3D (Pubitemid 36432317)
66. MS Anderson ES Venanzi Z Chen SP Berzins C Benoist D Mathis 2005 The cellular mechanism of Aire control of T cell tolerance Immunity 23 227 239 16111640 10.1016/j.immuni.2005.07.005 1:CAS:528:DC%2BD2MXpvVCnu7s%3D (Pubitemid 41169291)
67. W Li MG Kim TS Gourley BP McCarthy DB Sant'Angelo CH Chang 2005 An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population Immunity 23 375 386 16226503 10.1016/j.immuni.2005.09.002 1:CAS:528:DC%2BD2MXht1Shs77K (Pubitemid 41443439)
68. EY Choi KC Jung HJ Park DH Chung JS Song SD Yang E Simpson SH Park 2005 Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells Immunity 23 387 396 16226504 10.1016/j.immuni.2005.09.005 1:CAS:528:DC%2BD2MXht1Shs77L (Pubitemid 41443440)
69. AK Junker DA Driscoll 1995 Humoral immunity in DiGeorge syndrome J Pediatr 127 231 237 7636647 10.1016/S0022-3476(95)70300-4 1:STN:280: DyaK2MzmtlGqtw%3D%3D
70. KE Sullivan D McDonald-McGinn DA Driscoll BS Emanuel EH Zackai AF Jawad 1999 Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/ velocardiofacial syndrome) Clin Diagn Lab Immunol 6 906 911 10548584 1:CAS:528:DyaK1MXnvVymsbw%3D (Pubitemid 29529986)
71. AF Jawad DM McDonald-Mcginn E Zackai KE Sullivan 2001 Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/ velocardiofacial syndrome) J Pediatr 139 715 723 11713452 10.1067/mpd.2001. 118534 1:STN:280:DC%2BD3MnmslOhtw%3D%3D (Pubitemid 33097439)
72. C Cancrini ML Romiti A Finocchi S Di Cesare P Ciaffi C Capponi S Pahwa P Rossi 2005 Post-natal ontogenesis of the T-cell receptor CD4 and CD8 Vbeta repertoire and immune function in children with DiGeorge syndrome J Clin Immunol 25 265 274 15981092 10.1007/s10875-005-4085-3 1:CAS:528:DC%2BD2MXnsVehtb0%3D (Pubitemid 40884053)
73. A McLean-Tooke D Barge GP Spickett AR Gennery 2008 Immunological defects in 22q11.2 deletion syndrome J Allergy Clin Immunol 122 362 367 18485468 10.1016/j.jaci.2008.03.033 1:CAS:528:DC%2BD1cXpsVGgsLw%3D
74. K Lima TG Abrahamsen I Foelling S Natvig LP Ryder RW Olaussen 2010 Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+ CD45RA+ T cell counts and T cell receptor rearrangement excision circles Clin Exp Immunol 161 98 107 20491792 1:CAS:528:DC%2BC3cXps1enurs%3D
75. LM Piliero AN Sanford DM McDonald-McGinn EH Zackai KE Sullivan 2004 T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome Blood 103 1020 1025 14525774 10.1182/blood-2003-08-2824 1:CAS:528:DC%2BD2cXhtVaks78%3D (Pubitemid 38129565)
76. IM Pierdominic F Mazzetta E Caprini M Marziali MC Digilio B Marino A Aiuti F Amati G Russo G Novelli F Pandolfi G Luzi A Giovannetti 2003 Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) Clin Exp Immunol 132 323 331 10.1046/j.1365-2249.2003.02134.x (Pubitemid 36560631)
77. Sedivá A, Bartůnková J, Zachová R, Poloucková A, Hrusák O, Janda A, Kocárek E, Novotná D, Novotná K, Klein T (2005) Early development of immunity in DiGeorge syndrome. Med Sci Monit 11: CR182-187
78. P Eberle C Berger S Junge S Dougoud EV Büchel M Riegel A Schinzel R Seger T Güngör 2009 Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome Clin Exp Immunol 155 189 198 19040613 10.1111/j.1365-2249.2008.03809.x 1:STN:280:DC%2BD1M%2Fls1ymsg%3D%3D
79. A Herwadkar AR Gennery AS Moran MR Haeney PD Arkwright 2010 Association between hypoparathyroidism and defective T cell immunity in 22q11.2 deletion syndrome J Clin Pathol 63 151 155 20154038 10.1136/jcp.2009.072074 1:STN:280:DC%2BC3c7gsFChsg%3D%3D
80. SJ Kung KW Gripp MJ Stephan MP Fairchok SJ McGeady 2007 Selective IgM deficiency and 22q11.2 deletion syndrome Ann Allergy Asthma Immunol 99 87 92 17650836 10.1016/S1081-1206(10)60627-8 (Pubitemid 47075957)
81. A Finocchi S Di Cesare ML Romiti C Capponi P Rossi R Carsetti C Cancrini 2006 Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome) Pediatr Allergy Immunol 17 382 388 16846458 10.1111/j.1399-3038.2006.00409.x 1:STN:280:DC%2BD28visFGntg%3D%3D (Pubitemid 43989962)
82. MS Schubert RB Moss 1992 Selective polysaccharide antibody deficiency in familial DiGeorge syndrome Ann Allergy 69 231 238 1524280 1:STN:280: DyaK38zpvVWgtQ%3D%3D
83. AR Gennery D Barge JJ O'Sullivan TJ Flood M Abinun AJ Cant 2002 Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86 422 425 10.1136/adc.86.6.422 1:STN:280:DC%2BD383os1Gmtw%3D%3D (Pubitemid 34596653)
84. Brown JJ, Datta V, Browning MJ, Swift PJF (2004) Graves' disease in Di George Syndrome: Patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J Pediatr Endocrinol Metab 17: 1575-1579 (Pubitemid 39497012)
85. CA Smith DA Driscoll BS Emmanuel DM McDonald-McGinn EH Zackai KE Sullivan 1998 Increased prevalence of immunoglobulin A deficiency in patients with a chromosome 22q11.2 deletion syndrome (DiGeorge Syndrome/ Velo-Cardio-Facial Syndrome) Clin Diagn Lab Immunol 5 415 417 9606003 1:STN:280: DyaK1c3mslSnsg%3D%3D (Pubitemid 28246471)
86. K Davies RE Stiehm P Woo KJ Murray 2001 Juvenile idiopathic polyarticular arthritis and IGA deficiency in the 22q11 deletion syndrome J Rheumatol 28 2326 2334 11669177 1:CAS:528:DC%2BD3MXnvVCisL4%3D (Pubitemid 32947884)
87. RN Haire RD Buell RT Litman Y Ohta SM Fu T Honjo F Matsuda M de la Morena J Carro RA Good GW Litman 1993 Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome J Exp Med 178 825 834 8350056 10.1084/jem.178.3.825 1:CAS:528:DyaK3sXlsFOqtrw%3D (Pubitemid 23260420)
88. EE Perez A Bokszczanin D McDonald-McGinn EH Zackai KE Sullivan 2003 Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) Pediatrics 112 e325 14523220 10.1542/peds.112.4.e325
89. EH Moylett AN Wasan LM Noroski WT Shearer 2004 Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity Clin Immunol 112 106 112 15207787 10.1016/j.clim.2004.02.008 1:CAS:528:DC%2BD2cXltVOisrk%3D (Pubitemid 38781063)
90. C Azzari E Gambineri M Resti M Moriondo L Betti LRG Saldias AM Gelli A Vierucci 2005 Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome) Vaccine 23 1668 1671 15705470 10.1016/j.vaccine.2004.10.005 1:CAS:528:DC%2BD2MXhtlajs7c%3D (Pubitemid 40215699)
91. V Waters KS Peterson P LaRussa 2007 Live viral vaccines in a DiGeorge syndrome patient Arch Dis Child 92 519 520 16798784 10.1136/adc.2006.097493 1:STN:280:DC%2BD2szgt1Ohsw%3D%3D (Pubitemid 46867273)
92. CM Davis VS Kancherla A Reddy W Chan HW Yeh LM Noroski H Rosenblatt WT Shearer J Chinen 2008 Development of specific T-cell responses to Candida and tetanus antigens in partial DiGeorge syndrome J Allergy Clin Immunol 122 1194 1199 18789819 10.1016/j.jaci.2008.06.039 1:CAS:528:DC%2BD1cXhsV2ltr%2FE
93. N Al-Sukaiti B Reid S Lavi D Al-Zaharani A Atkinson CM Roifman E Grunebaum 2010 Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome J Allergy Clin Immunol 126 868 869 20810153 10.1016/j.jaci.2010.07.018
94. CP Kratz T Niehues S Lyding A Heusch G Janssen U Gobel 2003 Evans Syndrome in a patient with Chromosome 22q11.2 deletion syndrome: a case report Pediatr Hematol Oncol 20 167 172 12554529 10.1080/0880010390158685 1:CAS:528:DC%2BD3sXksVSkuw%3D%3D (Pubitemid 36222479)
95. SA Rasmussen CA Williams M Ayoube JW Sleasman BA Gray A Bent-Williams HJ Stalker T Zorir 1996 Juvenile rheumatoid arthritis in velo-cardio-facial syndrome: coincidence or unusual complication Am J Med Genet 64 546 550 8870920 10.1002/(SICI)1096-8628(19960906)64:4<546::AID-AJMG4>3.0.CO;2-N 1:STN:280:DyaK2s%2FisVKqsQ%3D%3D (Pubitemid 26296100)
96. AD DePiero EM Louire BW Berman NH Robin EB Zinn RW Hostoffer 1997 Recurrent immune cytopenias in 2 patients with Di George/velo cardio facial syndrome J Paediatr 13 484 486 10.1016/S0022-3476(97)80085-6 (Pubitemid 27495220)
97. A Verloes C Curry M Jamar C Herens P O'Lague J Marks P Sarda P Blanchet 1998 Juvenile rheumatoid arthritis and del (22q11) syndrome: a non-random association J Med Genet 35 943 947 9832043 10.1136/jmg.35.11.943 1:STN:280:DyaK1M%2FkvVyrsQ%3D%3D (Pubitemid 28486624)
98. JF Bach 2005 Infections and autoimmune diseases J Autoimmun 25 Suppl 74 80 16278064 10.1016/j.jaut.2005.09.024 1:CAS:528:DC%2BD2MXht1Ghs7vM (Pubitemid 41728049)
99. SH Schurman F Candotti 2003 Autoimmunity in Wiskott-Aldrich syndrome Curr Opin Rheumatol 15 446 453 12819473 10.1097/00002281-200307000-00012 1:CAS:528:DC%2BD3sXltFKjsbw%3D (Pubitemid 36774257)
100. R Zemble E Luning Prak K McDonald D McDonald-McGinn E Zackai K Sullivan 2010 Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) Clin Immunol 136 409 418 20472505 10.1016/j.clim.2010.04.011 1:CAS:528:DC%2BC3cXpvFSru7k%3D